Back to YC Companies

    Shield Bio

    Summer 2016
    Inactive

    Bringing 3rd generation, nanopore sequencing to healthcare to solve…

    28 people View on YC

    Shield Bio at a glance

    Y Combinator batch
    Summer 2016
    Status
    Inactive
    Industry
    Healthcare
    Team size
    28 people
    Location
    Not recorded
    Website
    Not recorded

    Every field above comes from the Y Combinator company record. Nothing is estimated.

    Compare Shield Bio with similar YC companies →

    About Shield Bio

    Shield Bio is a precision medicine company with a proprietary platform that enables reliable nanopore sequencing in under a minute, in a clinical setting. It is focused on bringing 3rd generation or "nanopore" sequencing into clinical use to deliver on the promise of precision medicine. Shield is initially using the technology to improve the treatment of infectious disease and address the unmet clinical need of sepsis, which kills 300,000 people a year in the US alone.

    Tags:
    Healthcare
    Genomics
    Nanotechnology